Primer on Pulsed Electrical Field Ablation: Understanding the Benefits and Limitations
Pulsed electrical field (PEF) energy is a promising technique for catheter ablation of cardiac arrhythmias. In this article, the key aspects that need to be considered for safe and effective PEF delivery are reviewed, and their impact on clinical feasibility is discussed. The most important benefit...
Saved in:
Published in: | Circulation. Arrhythmia and electrophysiology |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
American Heart Association, Inc
17-09-2021
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Pulsed electrical field (PEF) energy is a promising technique for catheter ablation of cardiac arrhythmias. In this article, the key aspects that need to be considered for safe and effective PEF delivery are reviewed, and their impact on clinical feasibility is discussed. The most important benefit of PEF appears to be the ability to kill cells through mechanisms that do not alter stromal proteins, sparing sensitive structures to improve safety, without sacrificing cardiomyocyte ablation efficacy. Many parameters affect PEF treatment outcomes, including pulse intensity, waveform shape, and number of pulses, as well as electrode configuration and geometry. These physical and electrical characteristics must be titrated carefully to balance target tissue effects with collateral implications (muscle contraction, temperature rise, risk of electrical arcing events). It is important to note that any combination of parameters affecting PEF needs to be tested for clinical efficacy and safety. Applying PEF clinically requires knowledge of the fundamentals of this technology to exploit its opportunities and generate viable, durable health improvements for patients. |
---|---|
AbstractList | Pulsed electrical field (PEF) energy is a promising technique for catheter ablation of cardiac arrhythmias. In this article, the key aspects that need to be considered for safe and effective PEF delivery are reviewed, and their impact on clinical feasibility is discussed. The most important benefit of PEF appears to be the ability to kill cells through mechanisms that do not alter stromal proteins, sparing sensitive structures to improve safety, without sacrificing cardiomyocyte ablation efficacy. Many parameters affect PEF treatment outcomes, including pulse intensity, waveform shape, and number of pulses, as well as electrode configuration and geometry. These physical and electrical characteristics must be titrated carefully to balance target tissue effects with collateral implications (muscle contraction, temperature rise, risk of electrical arcing events). It is important to note that any combination of parameters affecting PEF needs to be tested for clinical efficacy and safety. Applying PEF clinically requires knowledge of the fundamentals of this technology to exploit its opportunities and generate viable, durable health improvements for patients. |
Author | Asivatham, Samuel J. Deneke, Thomas Castellvi, Quim Neal, Robert E Verma, Atul |
AuthorAffiliation | Division of Cardiology, Southlake Regional Health Center, University of Toronto, Newmarket, Canada (A.V.). Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (S.J.A.). Division of Cardiology, Rhon-Klinikum Campus Bad Neustadt, Bad Neustadt, Germany (T.D.). Galaxy Medical, Inc, San Carlos, CA (Q.C., R.E.N.) |
AuthorAffiliation_xml | – name: Division of Cardiology, Southlake Regional Health Center, University of Toronto, Newmarket, Canada (A.V.). Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (S.J.A.). Division of Cardiology, Rhon-Klinikum Campus Bad Neustadt, Bad Neustadt, Germany (T.D.). Galaxy Medical, Inc, San Carlos, CA (Q.C., R.E.N.) |
Author_xml | – sequence: 1 givenname: Atul surname: Verma fullname: Verma, Atul organization: Division of Cardiology, Southlake Regional Health Center, University of Toronto, Newmarket, Canada (A.V.). Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (S.J.A.). Division of Cardiology, Rhon-Klinikum Campus Bad Neustadt, Bad Neustadt, Germany (T.D.). Galaxy Medical, Inc, San Carlos, CA (Q.C., R.E.N.) – sequence: 2 givenname: Samuel surname: Asivatham middlename: J. fullname: Asivatham, Samuel J. – sequence: 3 givenname: Thomas surname: Deneke fullname: Deneke, Thomas – sequence: 4 givenname: Quim surname: Castellvi fullname: Castellvi, Quim – sequence: 5 givenname: Robert surname: Neal middlename: E fullname: Neal, Robert E |
BookMark | eNqdjEFuwjAQRb2gElA4ALu5QMIMDmncXYmCisQiQsAWGTI0bo0j2UZcv1HFCfo3X_p6_43FwHWOhZgRpkQ5zcvNrqzqlBaUIiEW-UCMSGWUSCyyoRiH8I2YU0H5SBxrb27soXNQ323gBirLl-jNRVtYG7YNfJytjqZz73BwDfsQtWuM-4LYMqzY8dXEAP0GW3Mz8Q8NE_Fy1b1u-uxXka2rffmZPDobe8ePvT_Yn1rWNrYnJCnfMiUThc8kSpFcyn_efgGf509y |
ContentType | Journal Article |
Copyright | American Heart Association, Inc. |
Copyright_xml | – notice: American Heart Association, Inc. |
DOI | 10.1161/CIRCEP.121.010086 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 01337493-900000000-99135 |
GroupedDBID | --- .XZ .Z2 18M 53G 5VS 6J9 AAAAV AAHPQ AAIQE AAJCS AARTV AASCR ABASU ABBUW ABDIG ABVCZ ABXVJ ACDDN ACEWG ACGFO ACILI ACWDW ACWRI ACXJB ACXNZ ADBBV ADGGA ADHPY AEBDS AFDTB AFEXH AGINI AHQNM AHVBC AINUH AJIOK AJNWD AJZMW ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW BAWUL BQLVK C45 CS3 DIK DIWNM E.X E3Z EBS EEVPB EX3 F5P FCALG FL- GNXGY GQDEL HLJTE IKREB IN~ KD2 KQ8 KQB L-C ODMTH ODZKP OHYEH OK1 OPUJH OVD OVDNE OXXIT RAH RIG RLZ S4S TEORI TR2 TSPGW V2I W2D W3M W8F WOW |
ID | FETCH-wolterskluwer_health_01337493-900000000-991353 |
ISSN | 1941-3084 |
IngestDate | Thu Nov 14 18:59:41 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-wolterskluwer_health_01337493-900000000-991353 |
ParticipantIDs | wolterskluwer_health_01337493-900000000-99135 |
PublicationCentury | 2000 |
PublicationDate | 2021-September-17 |
PublicationDateYYYYMMDD | 2021-09-17 |
PublicationDate_xml | – month: 09 year: 2021 text: 2021-September-17 day: 17 |
PublicationDecade | 2020 |
PublicationTitle | Circulation. Arrhythmia and electrophysiology |
PublicationYear | 2021 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
SSID | ssj0061816 |
Score | 4.709178 |
Snippet | Pulsed electrical field (PEF) energy is a promising technique for catheter ablation of cardiac arrhythmias. In this article, the key aspects that need to be... |
SourceID | wolterskluwer |
SourceType | Publisher |
Title | Primer on Pulsed Electrical Field Ablation: Understanding the Benefits and Limitations |
URI | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=01337493-900000000-99135 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La8JAEF6sQmkppU_6Zg-9hdi8Nb0FG9HSFtta6U2SuEGpRojG0n_fmd1EY6VQD_WwyCLZsPMxM85-3ywh15ByKKbHNNkIdBgqqidXmWfKPgZTw9DC0MOabuO18vRevXMNt1DI6F2LuX-1NMyBrVE5u4a15w-FCfgONocRrA7jn-zewn79MZ4BtBIIez3J5RfdcFvUka4mOf5wTul4W9K2cLIAOL8QTxOwos7lT7maXtbSYBAH6bVfZcmJ4_7XtD8S6i4pvVeHV0yWSvYdjAHcFU0XZETYoBlW70eiOj1K2FC6L8-za3gXQR7K8Zj4gckExS8zzkR4TgajfO1CU5FoIaSaObmAhz29YL_ygFwhgqq2gXUycZ3cqtu30O3Xmi81t4X9MsoK9iz60WKbB23IePWKYeuyraQfGeCqmxukpIGrAk9ZcmrNh2YWzS3IgLhCLVs_PRmHFW9W1tsmO59jJDlMPrjGIZeptPfIbvoXgzoCG_ukwKIDsvmYkigOSUdAhI4jKiBCFxChHCI0g8gtXQIIBYDQDCAU5mgOIEfEqLvtWkNeermuENp2f9sR_ZgUo3HETgg1A7vqV1kYmCwwerbp6bYSeJYfKGrA1J51StZ79Nmavz8nWwv0XJDiNE7YJdmY9JKr1Fzf-ZdhZA |
link.rule.ids | 315,782,786,27933,27934,64549,64569,65344,65364 |
linkProvider | Ovid |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1LT4NAEJ7YNlET49v4dg-GG5WW5WXCgVKw1ZYQwdep4ZkYEzCl1b_vDtCkHjz0IgcghJAFNjPfznzfDMA1gxyCFCRdnkYi2ymdgFeTQOJDdKaUdtM0wJjuwFOcV7VvYZmcBVcVxWfFZxsPpZnGE2yHg-tCX7_3OMd68fSMMz1Tf-Nc484qw9RIkuD6ev6VzjjD0RmsERWqibwm1BvPxiRKDWjJkijTJrQMu-_3FiZbZm6ulCFpFIMxKq3TnwwN3ZjDR9NysQhDW8BCOAwob33nmMkuPkoi-5I7snf-6UV2YbvGq8SoJtgerCXZPqyP64z8ATy72B9gSvKMuHPmZmNilY118N8TG-lxxAgrvt0teVpW0hAGPUmPmdr0fVYQdo2UYqsqgngI1LZ8c8D_-giTSrU5-WvA4hE0szxLjoFIkaaGapJGUhLRWJMCUROiQA4joRMlnVg-gdUefbri_VewMfDHo8lo6DycwWYXOSrYEkI5h-ZsOk8uoFHE88t6ivwAWw_IjA |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1La4NAEB6aBEKh9F367h6KN1MT11fBg_HRpA-Rmr5OwccKpRBLTFr677ujBtJDD73Ugy6LyLqMM58z880AnHPIISkR64k0kflJ60aiziJFjNGYUtrLsgh9uoNQ8591x8UyOYsIPpLPivcOXko1jQNsh4P_hSPzOhTs0DZfBN99Ck1fCKwrt3RTY5KEEDie-SU4Zv6RzQTLNzm4kTVqyKIh1YfIVyYrDWipHDbwT6Blec6ov1DcKjd2JRnJoOiS0WkdBOWY6MIe3ttugKUYOhKWw-Fwee0zx3h28Vamsy8ZJW_jX19nE9Zr7EqsSti2YIVNtqF9V0fnd-AxwF4BU5JPSDDnJjclbtlkB-WAeJgqR6y4yr27JA_LrBrCYSjpc7Wbvc4KwudISbyqvIm7QD13ZA_EH1sxrhic498WLO9Bc5JP2D4QJTH0WGdZorCEpoYSyYaURGqcSN2EdVP1AP726MM_3n8Gbb7N49uhf3MEqz1MV8HuENoxNGfTOTuBRpHOT2s5-Qa8Sctu |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Primer+on+Pulsed+Electrical+Field+Ablation%3A+Understanding+the+Benefits+and+Limitations&rft.jtitle=Circulation.+Arrhythmia+and+electrophysiology&rft.au=Verma%2C+Atul&rft.au=Asivatham%2C+Samuel+J.&rft.au=Deneke%2C+Thomas&rft.au=Castellvi%2C+Quim&rft.date=2021-09-17&rft.pub=American+Heart+Association%2C+Inc&rft.issn=1941-3084&rft_id=info:doi/10.1161%2FCIRCEP.121.010086&rft.externalDocID=01337493-900000000-99135 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1941-3084&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1941-3084&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1941-3084&client=summon |